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Patient and carer involvement in palliative  
care research: An integrative qualitative 
evidence synthesis review
Eleni Chambers , Clare Gardiner , Jill Thompson and Jane Seymour
Abstract
Background: Patient/carer involvement in palliative care research has been reported as complex, difficult and less advanced compared 
to other areas of health and social care research. There is seemingly limited evidence on impact and effectiveness.
Aim: To examine the evidence regarding patient/carer involvement in palliative care research and identify the facilitators, barriers, 
impacts and gaps in the evidence base.
Design: Qualitative evidence synthesis using an integrative review approach and thematic analysis.
Data sources: Electronic databases were searched up to March 2018. Additional methods included searching websites and ongoing/
unpublished studies, author searching and contacting experts. Eligibility criteria were based on the SPICE (Setting, Perspective, 
Intervention, Comparison, Evaluation) framework. Two quality assessments on methodology and involvement were undertaken.
Results: A total of 93 records were included. Eight main themes were identified, mainly concerning facilitators and barriers to effective 
patient and carer involvement in palliative care research: definitions/roles, values/principles, organisations/culture, training/
support, networking/groups, perspectives/diversity, relationships/communication and emotions/impact. Evidence on the impact of 
involvement was limited, but when carried out effectively, involvement brought positive benefits for all concerned, improving the 
relevance and quality of research. Evidence gaps were found in non-cancer populations and collaborative/user-led involvement.
Conclusion: Evidence identified suggests that involvement in palliative care research is challenging, but not dissimilar to that 
elsewhere. The facilitators and barriers identified relate mainly to the conduct of researchers at an individual level; in particular, 
there exists a reluctance among professionals to undertake involvement, and myths still perpetuate that patients/carers do not want 
to be involved. A developed infrastructure, more involvement-friendly organisational cultures and a strengthening of the evidence 
base would also be beneficial.
Keywords
Community participation, co-production, engagement, palliative care, patient and public involvement, research, systematic review, 
user involvement
What is already known about the topic?
x Patient/carer involvement in palliative care research is reported as complex and challenging due to its association with 
end-of-life care and concerns for the vulnerability of patients/carers.
x Involvement in palliative care research is less advanced than in other areas of health and social care research.
x Limited evidence exists regarding the impact and effectiveness of involvement in palliative care research.
What this paper adds?
x The findings show that involvement in palliative care research is challenging but not dissimilar to that in other fields. 
Issues concerning power, diversity and emotions are magnified, leading to a reluctance among researchers to undertake 
involvement.
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Introduction
Public involvement in research is defined as research car-
ried out with or by members of the public rather than 
to, about or for them.1 INVOLVE, funded by the 
National Institute for Health Research (NIHR) to support 
involvement within England, includes patients and carers 
within this definition; however, professionals, including 
academics and clinicians, although also users of health 
and social care services, are excluded because of their 
role and resulting different perspectives they bring. 
Patient/carer involvement may occur throughout the 
research cycle and could include, for example, taking an 
active role in setting priorities for research, commenting 
on study design as a member of an advisory group or car-
rying out interviews. Involvement has been shown to 
bring benefits such as making the research more relevant 
and improving its quality.1
Involvement has increased in priority both in the 
United Kingdom and internationally, notably the United 
States, Canada, Australia and Europe, and is now driven 
by both policy and research funders.13 However, in some 
areas of health and social care research, it is less well 
developed. This seems apparent in palliative care, where 
involvement has a shorter history compared to other dis-
ciplines and is said to be more complex and challenging 
for numerous reasons.47 Palliative care is associated with 
end-of-life care and there can be unease at discussing 
death and dying.8,9 Patients/carers often experience high 
levels of symptom burden or have limited time,8,9 and pro-
fessionals may be reluctant to engage in research as it 
may feel too daunting or they may assume patients are 
too ill.1012 Structures such as ethical review and govern-
ance arrangements may provide additional barriers.13,14
Little evidence exists on involvement in palliative care 
research compared to other fields.15 Available guidelines 
and standards are general and fail to provide detail on the 
particular issues associated with involving this popula-
tion.1,2,16,17 There is limited literature on involvement in 
other palliative care settings, for example, education1820 or 
service provision.2125 The need for this review is therefore 
apparent, to promote more effective involvement in pallia-
tive care research, for the benefit of all, including clinicians, 
academics and patients/carers.2629
Aims
The primary aim was to systematically review the evi-
dence regarding patient/carer involvement in palliative 
care research. The secondary aim was to identify facilita-
tors, barriers and gaps in the evidence base.
Methods
A preliminary scoping review was undertaken to identify 
issues related to the definition of palliative care, the pop-
ulation, evidence type and study design; and used to 
define the eligibility criteria, search terms and search 
strategy for the subsequent review.
Subsequently, a qualitative evidence synthesis was 
used to enable diverse evidence to be incorporated and 
different perspectives and contextual factors to be consid-
ered.30 An integrative approach brought together differ-
ent types of data in terms of both study design and 
involvement approach.31 The Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis (PRISMA) 
guidelines were followed.32
Eligibility criteria
The SPICE framework (Setting, Perspective, Intervention, 
Comparison, Evaluation)33 was used to define the eligibil-
ity criteria, with additional criteria identified from the 
scoping review (Table 1).
Information sources and search
The scoping review identified a scarcity of published aca-
demic literature and a larger quantity of diverse grey evi-
dence, suggesting the need to use a wide variety of search 
methods.
x Specific strategies are proposed to develop involvement concerning access, flexibility and the use of different involve-
ment methods.
x Patients/carers value opportunities to be involved in research, including from the outset of studies.
Implications for practice, theory or policy
x Further exploration is needed of the highlighted issues to enable more collaborative, co-produced or user-led 
involvement.
x The findings show a need for education, guidance or standards to improve involvement practice and organisational 
culture.
x There is a need for further development of infrastructure to support involvement, including funding, training, support 
and networking opportunities.
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Health databases (AMED, CINAHL, Cochrane Library, 
MEDLINE, PsycINFO), social science and other databases 
(ASSIA, EThOS, Social Care Online, Open Grey, ProQuest, 
Web of Science) were searched. Websites of general 
health organisations (e.g. Joseph Rowntree Foundation), 
involvement-specific organisations (e.g. James Lind 
Alliance) and palliative care organisations in the United 
Kingdom and internationally (e.g. National Council for 
Palliative Care (NCPC), European Association for Palliative 
Care) were hand-searched. The INVOLVE website was 
searched for ongoing and unpublished research studies.
Bibliographies of key texts were checked to identify 
missing evidence and author searching was undertaken. 
Individual experts and specialist organisations were con-
tacted, including academics, clinicians and patients/car-
ers, notably a patient/carer involvement panel, Sheffield 
Palliative Care Studies Advisory Group (PCSAG).36 All 
searches were conducted between July and December 
2017, with an additional search in April 2019.
Components of the SPICE framework were combined 
and used to define the search strategies. Multiple terms 
were identified for each component and combined using 
Boolean operators. Free text searching was used to search 
databases and websites using these terms. Some data-
bases use MeSH terms; therefore, thesaurus searching 
was used in addition. Where possible, limit functions 
were used to limit searches, for example, to English lan-
guage. Similarly, filters were applied to restrict searches, 
for example, to adult populations only (Table 2).
Evidence selection
All retrieved evidence was screened for relevance using 
the eligibility criteria. Titles and abstracts of studies (or 
summaries in the case of grey literature) were screened 
together initially and the same process repeated with the 
full texts. Reasons for exclusion were recorded for trans-
parency. All references were entered into EndNote.
Data collection process
A data extraction form was developed, piloted on a sam-
ple of diverse evidence and adapted to ensure the opti-
mum extraction of relevant data. Data were extracted on 
key characteristics pertaining to both type of evidence 
and involvement.
Quality assessment
Two quality assessments were undertaken, concurrently 
with data extraction. The first related to the methodologi-
cal quality of the study or evidence and used the relevant 
critical appraisal tool from the Joanna Briggs Institute.37 
The second used critical appraisal guidelines developed 
specifically for appraising the quality of involvement in 
research.38 No evidence was excluded on the basis of 
quality, instead both checklists were used to provide a rat-
ing based on broad categories only (weak, moderate, 
strong), as has been found useful in other reviews.39,40
Table 1.ഩůŝŐŝďŝůŝƚǇĐƌŝƚĞƌŝĂ ?
Selection criteria Inclusion Exclusion
Setting Palliative carea research
Palliative care in other settings (e.g. education, service provision) 
if it relates to involvement at a higher level than the individual 
patient/carer, includes guidelines or standards, or is a key text of 
relevance to the review
Other areas of research
Palliative care in service provision at 
individual level with no involvement
No guidelines or standards
Perspective Anyone with experience of patient/carer involvement in palliative 
care research (e.g. patients, carers, clinicians, academics)
No experience of patient/carer 
involvement in palliative care research
Intervention Involvement No involvement
Comparison Not relevant Not relevant
Evaluation Any evidence on the effects of involvement, either on outcome or 
process (e.g. impact, benefits, barriers)
None
Age ŐĞĚ ? ?രǇĞĂƌƐĂŶĚŽůĚĞƌ ŐĞĚƵŶĚĞƌ ? ?രǇĞĂƌƐ
Countries Evidence concerning Western populations only Non-Western populations
Language English only Non-English
Type of evidence Any evidence or literature, including grey literature None
Study/evidence 
design
Any design, including reviews, qualitative, quantitative, mixed 
methods, text or opinion
None
Publication year Any year None
WHO: World Health Organisation; COPD: chronic obstructive pulmonary disease; MND: motor neuron disease.
aPalliative care defined broadly using the Global Atlas of Palliative Care at the End of Life,34 which widened the WHO definition35 to make it more 
comprehensive. Search terms related to palliative care expanded to include non-communicable life-limiting health conditions most relevant to 
Western countries34 and to ensure a diverse range of conditions to enable different involvement issues to be explored. The following were used: 
Alzheimers and other dementias, cancer, cardiovascular diseases, chronic respiratory conditions (e.g. COPD), diabetes and neurodegenerative con-
ditions (e.g. Huntingtons, MND, Parkinsons). Those aged under 18 were excluded because of the additional ethical and other issues raised.
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Independent verification
Evidence selection, data extraction and quality assessment 
were carried out by the lead author with contributions 
from all other authors. A sample of evidence was randomly 
selected and double-checked by the other authors and 
comprised a full screening process using the eligibility crite-
ria and completion of both quality assessments. Findings 
were compared and any differences resolved through dis-
cussion. Agreement was achieved on eligibility of evidence 
and broad rating categories for both quality assessments.
Synthesis of results
Thematic synthesis was used because the review questions 
were fixed and there was a large amount of evidence.30,41 In 
addition, thematic synthesis has been effectively used in 
similar reviews that explored peoples perceptions, includ-
ing the identification of barriers and facilitators.31,42
Synthesis involved several stages: data from each piece 
of evidence were extracted verbatim into tables and 
coded initially line-by-line, codes were combined to gen-
erate descriptive themes, and finally analytical themes 
were developed.41 An a priori framework was not used for 
initial coding but was developed from the codes itera-
tively during the first two stages, as further evidence was 
individually coded.
Patient and carer involvement in this review
The involvement of patients/carers in systematic reviews 
is still scarce, although it has been increasing in recent 
years.4345 Patients/carers were involved at several key 
stages. Initially, consultation was undertaken with a group 
of patients/carers, including members of the PCSAG on 
the identification of sources to be searched, search terms 
and the inclusion of different health conditions.
A further wider consultation took place with patients/
carers after the identification of the analytical themes, for 
validation purposes. Patients/carers described experiences 
and perspectives that resonated with the themes produced. 
They provided examples from their own involvement activi-
ties and highlighted particular areas they believed to be of 
importance. Additional issues were raised that had not pre-
viously been identified by the review (Supplemental mate-
rial: File 1. Patient/carer involvement). Patients/carers were 
offered gift vouchers as an appreciation of thanks.
Results
Evidence selection and characteristics
The searches identified 4688 potentially relevant records 
after duplicates were removed, resulting in 93 included 
records after screening. Reasons for exclusion are shown in 
the PRISMA flow diagram (Figure 1). Included evidence and 
characteristics are provided (Supplemental materials: File 2. 
Included evidence, File 3. Evidence characteristics).
Thematic findings
Eight main analytical themes were identified, which 
mainly described facilitators and barriers to effective 
patient and carer involvement in palliative care research: 
Table 2.ഩ^ĞĂƌĐŚƐƚƌĂƚĞŐŝĞƐ ?
SPICE components Thesaurus terms Free text terms
Setting ((Palliative care OR Palliative medicine OR Hospice 
care OR Terminally ill OR Hospice and Palliative Care 
Nursing OR Hospices) OR (Alzheimer Disease OR 
Dementia) OR
(Cancer OR Neoplasms) OR (Cardiovascular diseases) 
OR (Pulmonary Disease, Chronic Obstructive) OR
(Latent Autoimmune Diabetes in Adults) OR 
(Neurodegenerative Diseases OR Motor Neuron 
Disease OR Huntington Disease OR Parkinson 
Disease, Postencephalitic)) AND (research* OR study 
OR trial OR interview* OR project OR review)
((Palliative care OR Palliative medicine OR Hospice care 
OR Terminally ill OR Hospice and Palliative Care Nursing 
OR Hospices OR End of life care OR Terminal Care OR 
Supportive Care OR Non-curative Therapy OR Palliative 
Treatment) OR (Alzheimers OR Dementia) OR (Cancer 
OR Neoplasms) OR
(Cardiovascular disease OR CVD) OR (Chronic Obstructive 
Pulmonary Disease OR COPD) OR (Diabetes) OR 
(Neurodegenerative Disease OR Motor Neuron Disease 
OR MND OR Huntington Disease Huntingtons OR 
Parkinsons Disease)) AND (research* OR study OR trial 
OR interview* OR project OR review)
Perspective Not relevant Not relevant
Intervention Community Participation OR Patient Participation Involv* OR Engag* OR Participat* OR Co-produc* OR 
Collaborat* OR Partnership working OR Participatory 
Research OR Participatory Action Research OR 
Emancipatory Research OR Expert Patient OR Experts by 
Experience OR Research Partner
Comparison Not relevant Not relevant
Evaluation Not relevant Not relevant
SPICE: Setting, Perspective, Intervention, Comparison, Evaluation.
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definitions and roles, values and principles, organisations 
and culture, training and support, networking and groups, 
perspectives and diversity, relationships and communica-
tion, and emotions and impact (Figure 2). A summary 
table of the findings is provided (Table 3).
Definitions and roles.ഩŝĨĨĞƌĞŶƚ ƚĞƌŵŝŶŽůŽŐǇ ǁĂƐ ƵƐĞĚ ĨŽƌ
those involved, for example, lay stakeholders,46 research 
partners47 and service users.48 No one definition was appli-
cable across all evidence and it was unclear whether inter-
pretations of involvement were uniform.49,50 Similarly, the 
term palliative care was inconsistently used, with variations 
in health condition, including symptoms and stages25,51,52; 
service use, for example, specialist or generalist ser-
vices12,50,53,54; and inconsistencies concerning how end-of-
life was defined, boundaries between different types of care 
and the length of time a person was considered to be in 
need of palliative care.12,21,55,56 The discrepancies made it 
hard to conceptualise both involvement and palliative care.
The need for greater clarity of involvement roles was 
highlighted, particularly at the outset of studies when 
patients were unclear what was expected from them.6,28,57 
Evidence related to groups emphasised the need for a 
clear purpose.5,58 Initial expectations of what a group 
could achieve were vague, roles uncertain and relation-
ships with external bodies such as research networks 
confused.5,49 Researchers needed to take time to facili-
tate a safe space, explain the research and clarify roles 
and expectations.
It could take groups a year before they started to engage 
meaningfully with researchers  time was needed to learn 
the system and how to affect change.59 This slowness was 
frustrating for some but valuable to develop aims and work-
ing practices.50,60,61 The need for agreement by everyone 
Figure 1.ഩWZ/^DĨůŽǁĚŝĂŐƌĂŵ ?32
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was stressed and the importance of negotiating this 
throughout the study was described to enable ownership of 
the group. It was recommended that possible emotional 
impacts of involvement were discussed from the outset, 
including stressing that people need only share aspects of 
their personal experiences that they feel comfortable with.62
Figure 2.ഩDĂŝŶĂŶĂůǇƚŝĐĂůƚŚĞŵĞƐ ?
Table 3.ഩ^ƵŵŵĂƌǇŽĨƌĞƐƵůƚƐ ?
Main analytical theme Summary of key issues/learning
Definitions and roles x Difficulties in conceptualising involvement and palliative care due to use of different terminology
x Take time to clarify roles, purpose and expectations
x Take time to create a safe space and to work together collaboratively, acknowledging boundary 
issues
Values and principles x Similarity of values in involvement and palliative care
x Acknowledge difficulties; however, do not make assumptions
x Acknowledge and work with power issues
Organisations and culture x Consider involvement as a core activity, integrate throughout organisations
x Address practical matters to make systems more involvement-friendly
x Address issues concerning attitudes to involvement and emotional aspects
x Involvement found to be less daunting than originally thought
Training and support x Provide training opportunities for all, considering different motivations
x Address support issues
x Involve different people using different methods
Networking and groups x Develop infrastructure to enable networking and mutual support, build collaborations and 
develop new groups
x Take time to develop relationships
x Consider issues concerning sustainability of groups
Perspectives and diversity x View differing perspectives as all valuable
x Acknowledge and address issues concerning diversity
x Consider diversity rather than representativeness
Relationships and 
communication
x Take time to develop relationships
x Need for professionals to interact with patients/carers
x Ensure communication is accessible and regular, provide feedback
x Acknowledge value and benefits of involvement
Emotions and impact x Acknowledge and address issues concerning emotional impact
x Ensure good practice followed in involvement
x Acknowledge positive benefits and impacts
x Ensure patients/carers offered opportunities to be involved
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Boundaries between patients/carers and professionals 
were sometimes challenged as many people were in fact 
juggling several different roles.63,64 Researchers had to 
decide how much of their own personal experiences to 
reveal.65 One described a merging between his profes-
sional and personal roles; he found himself becoming 
friendlier with members of the patient group and felt his 
professional identity was being challenged, as he shifted 
from being paternalistic to a more equal position.66
Values and principles.ഩdŚĞǀĂůƵĞƐŝŵƉůŝĐŝƚǁŝƚŚŝŶŝŶǀŽůǀĞ-
ment were described as similar to those in palliative 
care,49,67 and included transparency, accountability and 
honesty, for example, the importance of congruency 
between real and stated aims.61,62 Respect, trust and lis-
tening were necessary to develop collaborative relation-
ships between patients and researchers.7,61,67 Flexibility 
enabled people to decide when and how to be involved  
important for carers who had responsibilities and patients, 
whose health condition may fluctuate or progress.68
Particular approaches, notably Participatory Action 
Research, Community Based Participatory Research and 
emancipatory research, were suggested as being effective 
in promoting involvement.6972 These approaches used 
principles of equity, power-sharing and reciprocal transfer 
of knowledge and skills.49,55,73 However, the evidence was 
limited because they had not been widely or comprehen-
sively used.55,69
Power was a recurrent theme, significantly the need to 
avoid tokenism or tick-box involvement. Sometimes roles 
were limited, patients had a voice but little authority for 
decision-making,50,51,74 or involvement was used to meet 
the organisations agenda rather than that of patients.71,75 
Furthermore, involvement had the potential to be exploit-
ative  thought to be important due to the potential vul-
nerability of patients/carers.12,21,67,75 Even when partic- 
ipatory methods were used, inequalities of power and 
influence were reported, the experiential knowledge of 
patients/carers could be overshadowed by academics 
research knowledge, and the drive for research usually 
came from academics.63,70,71,76 The importance of bridging 
different world views was highlighted.72 Sometimes 
patients felt obliged to take part in involvement or were 
concerned about possible repercussions to their care if 
they expressed negative opinions. The grateful patient 
syndrome was mentioned, where people at a difficult 
time in their life may be overly positive77 and older people 
were less likely to be negative.25
Patients/carers were often experiencing massive 
change and had fears for the future. Some had little time, 
non-essential commitments may be rejected or people 
may be pre-occupied with other things. Patients may be 
feeling unwell or experiencing fatigue, some had highly 
symptomatic conditions, a short disease duration, poor 
prognosis or may be facing death. Carers were facing 
bereavement, coping with loss or the prospect of loneli-
ness.12,21,66,74,78,79 Therefore, many professionals were 
concerned about overburdening people or felt it inappro-
priate to contact patients as they may die before seeing 
any changes resulting from their involvement.21,49,51,80 
Gatekeeping by clinicians could also be a barrier,50,56,69,71,81 
for example, a hospice refused to allow patients to be 
involved until their own Ethics Committee had cleared the 
study.77 The ethical concerns of involvement needed to be 
balanced with not making assumptions or removing 
choices from people.21,56,66,67
Organisations and culture.ഩ/ŶǀŽůǀĞŵĞŶƚ ǁĂƐ ŝŶĨůƵĞŶĐĞĚ
by wide contextual factors including international perspec-
tives and local politics46,51; however, organisational culture 
was also highly significant.4,50,67,82 Involvement needed to 
be considered a core activity, integrated throughout organ-
isations at different levels5,49,56,83; however, systems often 
were not perceived as being involvement-friendly. Com-
peting considerations existed; pressures on staff, heavy 
workloads and cutbacks in the context of austerity all 
made involvement difficult.4,51,60,84 Practical matters of 
administration, finances and travel needed to be addressed 
to avoid complicated bureaucratic practices.65,84
Despite this, there was much commitment and sup-
port shown from professionals,4,51,57,59,64,77,84,85 including, 
importantly, those in senior positions.4,50,86 Conversely, 
professionals were also reported as being disinterested, 
dismissive or displaying a lack of understanding of involve-
ment.5,58,60,67 Some were described as fearful or uncom-
fortable; they felt involvement was too impractical or 
unrealistic.51,74 The representativeness of patients was 
questioned; some patients were thought to have their 
own personal agendas.82 People were labelled as the 
usual suspects, causing annoyance and offence.5,57 
Sometimes patients were considered to be too close to 
their diagnosis; at other times, professionals felt their 
treatment occurred too long ago.87 There were concerns 
that people were not competent, that they would not 
consider legal, funding or other organisational con-
straints.65 These issues were poorly addressed, preventing 
patients from expressing their views.49
Nevertheless, there were encouraging progressions over 
time.59,70,88 In evaluations, clinicians reported more positive 
views about involvement activities, which were previously 
small scale but now more sophisticated, focussing on larger 
service development issues.50,51,84 Researchers increased 
their understanding of and commitment to involvement, 
and there was a shift in ideology away from paternalistic or 
superficial approaches. Professionals were surprised that 
patients raised issues that were small and achievable rather 
than large issues which required resources. They realised 
patients views were not as challenging as anticipated and 
involvement not as daunting as first believed, thereby also 
increasing their confidence.6,51,74
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Training and support.ഩKŶŐŽŝŶŐƚƌĂŝŶŝŶŐĂŶĚƐƵƉƉŽƌƚǁĞƌĞ
recommended for all, including professionals.7,50,56,58,67 
Some organisations had developed specific programmes, 
providing induction, training and scientific mentoring.6,49 
Training on involvement, funding, organisational struc-
tures, team building and research methods was pro-
vided.60,86 Patients/carers appreciated being able to keep 
up to date with current knowledge and research.89 Involve-
ment from the outset was important, to enable appropri-
ate training and support to be developed in partnership 
with patients/carers.7,54,76 The different motivations for 
wanting to be involved needed to be addressed, including 
poor or excellent treatment, wanting to give back, training 
opportunities and notably a desire to influence and 
improve both research and service provision.5,87
However, numerous practical constraints were reported, 
including meeting times or the use of venues such as hospi-
tals which may hold unpleasant memories.51 Involvement 
needed to allow people to engage with ease, therefore 
meetings needed to accommodate those who may be ill, 
experiencing pain or discomfort, have limited energy or a 
limited attention span.8,90,91 Informality was important, so 
people could move around or take medication.62,66 
Meetings/training should not last too long, breaks were 
useful and presentations should be kept short.49,89,92
Flexibility and accessibility were required as people 
sometimes could not commit regularly or long 
term.28,50,73,89 Sometimes one involvement method was 
used initially, for example, an advisory group, but then, if 
people became unwell, email communication was pre-
ferred.28 Initiatives such as keeping reflexive diaries and 
using de-brief time after events were recommended, if 
people did not want or were unable to participate in 
groups.65,68,74,77 Other support mechanisms included peer 
mentoring or attending events with family/friends.49,51,58,93 
Advocacy may be helpful, so patients could speak on 
behalf of others who may be too unwell.50
Not every involvement method was suitable for every-
one, each brought advantages and disadvantages. The use 
of several methods, adapted to suit different communi-
ties, was useful to enable a range of people to be invol
ved.6,28,56,65,67 Methods included newsletters, website sto-
ries, talks at organisations and other outreach methods, 
telephone and email.68 Developments in IT had made vir-
tual interaction more feasible, therefore not requiring 
physical presence at meetings  online training, video 
conferencing and online communities were all sug-
gested.8,47,49 One study had developed an online involve-
ment forum.6,94
Networking and groups.ഩĐĞŶƚƌĂůŝƐĞĚŶĞƚǁŽƌŬŝŶŐƌĞƐŽƵƌĐĞ
for professionals and patients/carers was suggested, to 
provide co-ordination, reduce duplication, and share infor-
mation and learning. Professionals highlighted the impor-
tance of building alliances and linking to local organisations, 
for example, patient forums.28,50,51,82 Patients wanted assis-
tance with developing new groups, particularly patient-led 
organisations, and gaining mutual support.5,25,28,84
Patient/carer advisory groups were common involve-
ment methods,62,70,71,74,77,95 with members often also 
active elsewhere, for example, involved in service provi-
sion.82,83 There were particular challenges regarding the 
stability of patient groups, including a lack of funding.58,80 
Clinicians could help establish and publicise groups, and 
provide ongoing support, for example, free meeting 
space.25 However, it was important for professionals to 
facilitate group collaboration, not discriminate between 
patient groups, and to step back to allow patients to 
implement their own agendas.25
Some people were initially anxious on joining a group; 
it took time for relationships to develop and members to 
feel comfortable. Several groups showed an element of 
peer support  not the intended purpose but often 
needed due to the nature of palliative care.5,25 However, it 
was difficult to sustain the long-term survival of groups 
and the loss of influential members caused groups to 
destabilise.25,87 There was a need for continuous recruit-
ment and succession planning.50,58
Tensions were reported when individuals dominated 
discussions. Often conflicts were self-managed, but it was 
important to give time to these process issues.25,58,62,86 
Facilitation was sometimes demanding because when 
people spoke of their personal experiences, it could be 
hard to move the conversation on.7,92 The composition of 
groups was discussed. Mixed panels of professionals and 
patients provided better networking opportunities but 
could be harder to facilitate to enable patients to have a 
meaningful contribution.60,86 It may be helpful if patients 
outnumbered professionals85 or if the chair was a patient/
carer.51,82 Some groups aimed to be more participatory in 
approach but this was unusual and required increased res
ources.48,67,80,96
An evolutionary process of group development over 
time was reported, as knowledge, expertise and confi-
dence grew.6,50,59,60,83 Initially group members were 
engaged mainly in consultations, for example, reviewing 
patient information. They then undertook more collabo-
rative involvement, such as becoming peer researchers or 
co-applicants on funding bids.65,74,84,9698 As groups gained 
experience, they established more influential relation-
ships with professionals, took more pro-active roles in 
decision-making, and contributed to policy and develop-
ment.4,49,59,60,82,96 Some also started thinking about their 
own research ideas as patient-led projects.47,99
Perspectives and diversity.ഩŝĨĨĞƌĞŶĐĞƐ ŝŶ ƉĞƌƐƉĞĐƚŝǀĞƐ
were common, mainly between patients/carers and the 
dominant perspective, professionals.28,46,51,84,92,100 There 
was a need to make the patient/carer voice more visible 
throughout, including in dissemination.28,50,61,71,75,83 It may 
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be helpful to view differing perspectives as not in compe-
tition, but as different opinions that all needed to be 
understood to reach a solution.65 For example, in studies 
where patients undertook data analysis, different themes 
were identified from that of researchers alone.76,80,93,101
Perspectives were particularly relevant for research 
that used Nominal Group Techniques, including Priority 
Setting Partnerships (PSPs) or similar,28,61,68,79,90,91,102104 or 
Delphi studies.105,106 PSPs were often driven by clinicians 
suggesting a need for greater involvement, to enable 
patient/carer priorities to be included rather than merely 
validating those identified by professionals.75,103,106 
Facilitators of groups/workshops needed to ensure that 
no stakeholder groups dominated or were excluded. For 
example, there may be conflicts between patients and 
carers.12,61,77
Greater diversity in involvement increased the credibil-
ity of research findings and/or obtained more relevant 
priorities; however, difficulties were often reported.7,56,103 
The exclusion of some groups  people from Black, Asian 
and minority ethnic (BAME) backgrounds, those on a 
lower income or with a non-cancer condition  reflected 
their exclusion in palliative care service provision.49,77 For 
others, older people or those in rural communities, practi-
cal considerations of transport and access were exacer-
bated.6,12,107 Younger people and those with rare 
conditions could also be excluded,62,96 and some people 
were self-conscious or reluctant to mix with others, for 
example, people with laryngectomies.25 The exclusion of 
those at the end of life was also highlighted,12,99 although 
one PSP had focussed solely on this group90,108  other 
PSPs used weighting mechanisms to ensure patient priori-
ties were reflected.79,103 Recruitment from marginalised 
communities required greater resources and different 
approaches, for example, outreach methods or regional 
recruitment for those with rarer conditions.7,25,49
Several papers commented that the right type of 
patient seemed to be, for example, in better health, English 
speaking, had access to IT and available in the daytime!62,87 
Such patients could be recruited to the exclusion of others 
as they were more accessible to professionals, sometimes 
hand-picked with no open recruitment processes.49,87 
Often recruitment was solely from existing patient/carer 
groups, thereby creating further exclusion as most people 
are not a member of any group.12,25,49,75 Groups served 
some conditions better than others  some had no or few 
groups, in particular, rarer conditions.25,96,102
The word representative caused difficulties; aiming 
for diversity rather than representativeness was recom-
mended.21,65,75,82 Demographic factors and health condi-
tions could be used for recruitment, along with those with 
different experiences and attitudes, for example, patients 
who volunteer, enthusiastic patients, hard to reach 
patients, alienated and sceptical patients, isolated 
patients, patients who are very ill, carers, family members 
and friends.21
Relationships and communication.ഩ/ƚ ǁĂƐ ŝŵƉŽƌƚĂŶƚ ĨŽƌ
professionals to develop collaborative relationships, have 
ongoing conversations and establish a two-way dialogue 
 not just email asking for comments.84,93,97 Sometimes it 
was difficult to build relationships6,94 or it took longer as 
communities became involved in their own ways, in their 
own time.57,69,72 There was sometimes mutual suspicion 
between patients/carers and professionals with a result-
ing need to develop a common agenda and work towards 
unified goals.25 Participatory approaches were suggested, 
whereby different groups can come together to co-
develop a vision for research.72 A willingness to remain 
open, listen, revise expectations and try new things all 
helped.87 It was suggested the best way for professionals 
to learn was to interact with people with life-limiting con-
ditions or experiencing bereavement. The ability to listen 
to awful stories was thought to be valuable.50
Communication needed to be accessible, as compli-
cated technical language and jargon could alienate some 
people.6,7,50,66,91,109 Researchers were able to communi-
cate regularly with academic colleagues; however, this 
was not possible with patients/carers. Lack of feedback 
was therefore sometimes an issue, resulting in patients 
feeling frustrated with not knowing what had happened 
to their views or if any action had resulted.28,56,57,65,68 It 
was important to keep patients/carers regularly updated, 
for example, via newsletters.77,80 Emerging findings could 
also be provided in case patients/carers were unable to 
receive final study results.49,89
Relationships formed or were strengthened, team-
work was developed and barriers broken down.50 There 
was increased dialogue and communication, contributing 
to organisational change. Boundaries were positively 
blurred between patients/carers and professionals, as 
involvement began to be perceived as a joint process 
with shared responsibilities.51,97,98 Throughout studies, 
patients/carers challenged assumptions, asked questions 
and influenced professional complacency. They brought 
common-sense to meetings and kept discussions 
grounded in reality.50,74,80,92,110
Emotions and impact.ഩ/ŶǀŽůǀĞŵĞŶƚ ŝŶ ƉĂůůŝĂƚŝǀĞ ĐĂƌĞ
could have a profound effect and high emotional cost. 
Sometimes it affirmed peoples experiences of disrespect-
ful services or brought back memories of loved ones who 
had since died.5,28,62,74 The ill-health and death of fellow 
group members or participants caused distress.63,66,74,109 
One paper reported that people shed tears at every 
event.63 Sometimes patients/carers had to withdraw 
from involvement as a result.21,109 Conversely, few profes-
sionals described any such emotional attachment.82
Involvement itself also caused distress, as activities 
could be carried out poorly, for example, it could be dis-
empowering to sit on an intimidating committee.25,58,75,77 
Sometimes patients experienced unrealistic expectations 
from professionals regarding their health or available 
10 Palliative Medicine 00(0)
time.49,71 People could feel overwhelmed by the pressures 
of involvement, issues connected with power imbalances 
or upsetting attitudes of professionals, for example, when 
health conditions were discussed insensitively.5,57
However, many more positive impacts were reported. 
Patients commonly described involvement as giving 
them a focus, motivating them to carry on in life.5 
Coming together in groups was reassuring and confi-
dence boosting; being with others with the same health 
condition could be beneficial and some were seen as 
role models.5,50,98 Other social benefits included net-
working, making friends and gaining mutual support. 
Working together, including with professionals, brought 
a sense of solidarity and comradery.57,66,80 Patients/car-
ers increased their knowledge of research and ethical 
issues.28,57 Researchers gained a greater understanding 
of palliative care, the experiences of the communities 
they were working with and what it was like living with 
particular health conditions.46,72,74
Patients found that involvement improved their rela-
tionship with their illness, helping them to come to terms 
with it. They learnt more about themselves, their health 
condition and how to better live with it.57,109 It gave them 
a sense that something positive had come out of the 
sometimes negative experiences of diagnosis and treat-
ment and helped to dispel feelings of hopelessness. Some 
commented that involvement had enabled them to think 
more about palliative care and to take responsibility for 
planning their own death.5,50,57,66 Carers too found that 
being involved eased difficult feelings regarding their 
experiences.111
Other psychological benefits included increased self-
confidence and feelings of empowerment. Involvement 
was seen as a positive way to keep active and combat 
depression and loneliness. A sense of personal achieve-
ment was gained and people felt recognised and valued 
for their contribution.5,57,83 Their expertise in their own 
condition was acknowledged but they were not just being 
defined as a patient, they felt helpful and able to do some-
thing again. Sometimes, people went on to be involved in 
further research, study or other activities.66,85,110
Despite the challenges, patients/carers were still keen 
to be involved and reported strong emotional attach-
ments to involvement.22,48,82,87 Members of one group 
described how they had not considered giving up, despite 
the fact that several members had died. They described 
their involvement as fun.5
Discussion
This is the first study to systematically review patient and 
carer involvement in palliative care research. Eight main 
themes were found: definitions and roles, values and 
principles, organisations and culture, training and sup-
port, networking and groups, perspectives and diversity, 
relationships and communication, and emotions and 
impact. These are consistent with themes found else-
where on involvement in health and social care research, 
both in the United Kingdom and internationally.112115
The evidence identified, although considerable, was 
predominantly qualitative or text/opinion in design, from 
the United Kingdom and concerned cancer. Furthermore, 
the quantity of publications has not increased significantly 
over recent years. The majority of involvement methods 
identified were consultative. Some more collaborative or 
co-produced initiatives were found, although collabora-
tion featured as an element only in these. No studies were 
user-led or user-controlled.1,116 These limitations in the 
evidence base illustrate the slow progression and particu-
lar difficulties associated with involvement in this field, 
when compared to mental health or disability research, 
for example.3,117,118
The evidence was largely comprised of facilitators and 
barriers, with limited evidence of impacts identified. 
Several prominent themes were highlighted. As in other 
fields, power was significant, influencing involvement 
throughout the research cycle.2,114 However, the range of 
issues reported from differing perspectives suggests there 
is a greater power imbalance between patients/carers 
and professionals than in other fields, and a resulting 
magnification of the complexities. The perceived vulnera-
bility of patients/carers by professionals was frequently 
cited as a barrier, supporting existing evidence from other 
disciplines.119,120 Furthermore, myths still perpetuate that 
patients/carers do not want to or are unable to take part 
in palliative care research as participants, let alone under-
take involvement.56,121,122 This review challenges such 
assumptions as being paternalistic and increasing margin-
alisation and exclusion. Both the review and consultation 
show that patients/carers value involvement opportuni-
ties, and moreover, from the outset, to enable them to 
input into their role and the involvement methods used.
Diversity was a further important theme, again 
reflected elsewhere.119,123 The lack of diversity found 
among those involved was shown to reflect many of the 
inequalities found in the wider context of palliative care 
service provision, where some communities receive lim-
ited palliative care services or a poorer quality of care, 
including patients with non-cancer conditions, people 
from BAME backgrounds, older people and those living in 
deprived areas.124126 To increase diversity, there needs to 
be greater emphasis on the process of involvement, to 
address issues such as access and flexibility, using a vari-
ety of involvement methods, adapting or changing them 
over time. The evidence base for this is gradually develop-
ing, with studies in palliative care and other fields begin-
ning to use more innovative approaches.6,56,127129
A contrast was illustrated of how emotions were 
addressed from different perspectives. Patients/carers 
were open in relaying both the positive impacts and often 
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complex profound sentiments concerning their involve-
ment, whereas few professionals reported emotional 
impacts, usually keeping any personal experiences of pal-
liative care hidden.63,65,82 Exceptions to this were studies 
that used more participatory approaches, in which profes-
sionals were less reserved, acknowledged their multiple 
or changing roles, and where a blurring of boundaries 
between patients/carers and professionals was found to 
be helpful to the involvement process.51,63,65,66,77
Finally, although the limited evidence found on impact 
is in line with reporting of involvement elsewhere,7,114,130,131 
it is apparent that when involvement was carried out 
effectively, there were positive benefits for all concerned, 
patients/carers, clinicians and researchers, in addition to 
improving the relevance and quality of the research.
Strengths and limitations
A key strength is the comprehensive search and broad 
inclusion criteria, resulting in the identification of a signifi-
cant amount of diverse evidence. It is possible the evi-
dence is not reflective of all involvement as only published 
involvement initiatives were reviewed; however, satura-
tion became apparent as new records did not identify 
new themes.132
The quality of evidence was variable in terms of both 
methodology and involvement; however, all available evi-
dence was used in order to maximise understanding. The 
exclusion of evidence pertaining to those under 18 or non-
Western populations may have resulted in some omissions; 
however, palliative care services and involvement practices 
were considered to be incomparable between these popu-
lations. The integrative approach enabled all evidence to be 
brought together. Thematic synthesis allowed both differ-
ent perspectives and contexts to be explored.
The involvement of patients/carers at several key 
stages widened the search terms and sources searched, 
identifying grey literature in particular, thereby increasing 
the comprehensiveness. Later, patients and carers not 
only validated themes but also provided additional data 
not found in the review. Increased collaboration may have 
further strengthened the review.
Unclear definitions of both involvement and palliative 
care were evident throughout. This could be seen as a 
limitation; however, it is believed that the evidence still 
provides beneficial data and moreover simply reflects the 
blurred boundaries and intricacies often present in both 
involvement and palliative care.133136
Implications for future research and 
development
The limited evidence base, in particular the lack of rigor-
ous evidence on the impact and effectiveness of involve-
ment, suggests the need for further research in areas not 
previously evaluated, notably non-cancer conditions and 
more collaborative, co-produced or user-led research. 
Prominent themes of power, diversity and emotions 
could be explored further, including the apparent reluc-
tance of professionals to undertake involvement. 
Although involvement was shown to have developed 
over time, as elsewhere,137139 there is a need for educa-
tion or guidance to improve both improvement practice 
and organisational culture.
Few organisations exist that specifically support 
involvement in palliative care research. Patient/carer 
groups encounter difficulties in establishing and sustain-
ing themselves.85,140 Palliative care organisations tend to 
focus on service provision,141,142 or have not yet explored 
involvement in research,143,144 and involvement-specific 
organisations have seldom considered the additional 
complexities inherent in palliative care research.145,146 
Evidence is rarely shared between organisations and 
involvement practices in other settings, notably service 
provision and education, are rarely shared. There is there-
fore a need for further development of infrastructure to 
support involvement, including funding, training, support 
and networking opportunities.
Conclusion
This review is the first to synthesise evidence related to 
involvement in palliative care research and has identified 
significant themes which need to be addressed to further 
the development of involvement in this field. Given the 
increase in the older population and resulting need for pal-
liative care services, this is a growing topical concern.147
This review suggests that at present many professionals 
feel reluctant or unable to undertake patient and carer 
involvement in a palliative care research context. Increased 
education or guidance, the development of infrastructure, 
more involvement-friendly organisational cultures and a 
strengthening of the evidence base would enable more 
effective involvement in palliative care research, thereby 
improving both research and service provision.
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